Cell line development is a fundamental process in biotechnology and the pharmaceutical industry for producing biological drugs, disease research, and developing new therapies. Commercializing biological drugs and the quality development of cell lines demands a partner with experience - an expert with an extensive portfolio of cutting-edge technologies, and customer support. It requires a partner that can reduce risks, optimize results, and increase your lab productivity.
In cooperation with our partner Sartorius, we provide Cell Line Development services to our customers, which are performed in the most modern Sartorius laboratories in this part of Europe. The 4Cell® CHO technology and over 240 developed cell lines are guarantees of successful cell line development. Banking cell lines in RCB (Research Cell Bank), MCB (Master Cell Bank), and WCB (Working Cell Bank) ensure long-term availability and stability of the cells for future needs.
From DNA to research cell bank (RCB) in just 9 weeks with titers up to 10g/L. Complete outsourcing of cell line development can save up to 19 months in process optimization. Sartorius technology for early identification of stable, scalable, and high-titer cell lines — CellCelector™, Octet®, iQue® 3, and Ambr® 15—simplifies early-stage development and ensures a seamless transition to production.
Leverage 4Cell® CHO, Sartorius' leading cell line development technology, supported by Sartorius 4Cell® SmartCHO media, to achieve exceptional performance, scalability, and flexibility in the production process with